Low in vitro resistances to 5 fluorocytosine in Candida and Cryptococcus neoformans isolates from Chile and Spain

被引：0
|
作者：
Torres-Rodríguez, JM [1 ]
Morera, Y [1 ]
Silva, V [1 ]
Díaz, MC [1 ]
机构：
[1] Univ Autonoma Barcelona, Fac Med, IMAS, IMIM,GREMEC, E-08193 Barcelona, Spain
来源：
TRENDS IN MEDICAL MYCOLOGY | 2003年
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Minimal Inhibitory Concentrations to 5-fluorocytosine (FC) of 89 isolates of Candida sp and I I of Cryptococcus neoformans were determinate using the standardised microbroth method M27-A (NCCLS). Only one of 63 isolates of C albicans was resistant to FC. C krusei showed the lowest susceptibility with a geometric mean of 9.2 mug/ml (MIC50% 8 mug/ml), meanwhile the other species were full susceptible (MIC less than or equal to 0.125 mug/ml) No resistances were found in C. neoformans (MIC 50% = 4 mug/ml). Yeasts isolates from Chile and Spain where the clinical use of FC is uncommon are exceptional, except with C. krusei.
引用
收藏
页码：159 / 163
页数：5
相关论文
共 50 条
  • [1] Isolates of Cryptococcus neoformans serotype A or D from cerebrospinal fluid resistant to 5-fluorocytosine
    Arsic, V
    Mitrovic, S
    KranjcicZec, I
    Dzamic, A
    JOURNAL OF CHEMOTHERAPY, 1995, 7 : 90 - 92
  • [2] In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients
    Hoban, DJ
    Zhanel, GG
    Karlowsky, JA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1463 - 1464
  • [3] 5-FLUOROCYTOSINE RESISTANCE IN CRYPTOCOCCUS-NEOFORMANS
    BLOCK, ER
    JENNINGS, AE
    BENNETT, JE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 3 (06) : 649 - 656
  • [4] THE GENETIC-BASIS OF RESISTANCE TO 5-FLUOROCYTOSINE IN CANDIDA SPECIES AND CRYPTOCOCCUS-NEOFORMANS
    WHELAN, WL
    CRC CRITICAL REVIEWS IN MICROBIOLOGY, 1987, 15 (01): : 45 - 56
  • [5] Molecular epidemiology of isolates of the Cryptococcus neoformans species complex from Spain
    Frases, Susana
    Ferrer, Consuelo
    Sanchez, Manuel
    Francisca Colom-Valiente, Maria
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2009, 26 (02): : 112 - 117
  • [6] Serotyping of Cryptococcus neoformans isolates from clinical and environmental sources in Spain
    Baro, T
    Torres-Rodriguez, JM
    Morera, Y
    Alía, C
    López, O
    Méndez, R
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) : 1170 - 1172
  • [7] VARIABLES INFLUENCING SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS TO 5-FLUOROCYTOSINE
    BLOCK, ER
    JENNINGS, AE
    BENNETT, JE
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1973, 4 (04) : 392 - 395
  • [8] In vitro mating of Colombian isolates of the Cryptococcus neoformans species complex
    Escandon, Patricia
    Ngamskulrungroj, Popchai
    Meyer, Wieland
    Castaneda, Elizabeth
    BIOMEDICA, 2007, 27 (02): : 308 - 314
  • [9] In vitro antifungal susceptibilities of Cryptococcus neoformans isolates in Southwest China
    Lei, Y.
    Kang, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S126 - S126
  • [10] In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole
    Davey, KG
    Johnson, EM
    Holmes, AD
    Szekely, A
    Warnock, DW
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) : 217 - 220
12345